Riskpilot← Back to searchSign inGet full accessSPECIALLÆGERNE I ØSTERGADE ApS
APSActiveCVR 32080685Østergade 9, 3.Medical specialists activities · NACE 8622Est. 20098 employees
Revenue 2024
DKK 10,9M
+1% vs 2023
EBITDA margin
54.9%
+1% vs 2023
Equity ratio
78.2%
Financial strength
Net profit 2024
DKK 4,1M
-7% vs 2023
| Revenue | DKK 10,9M | +1% |
| EBITDA | DKK 6M | +1% |
| Net profit | DKK 4,1M | -7% |
| Total assets | DKK 8,8M | +0% |
| Equity | DKK 6,9M | +2% |
| Employees | 8 | — |
Legal name
SPECIALLÆGERNE I ØSTERGADE ApS
CVR number
32080685
Legal form
Anpartsselskab
NACE code
8622 · Medical specialists activities
Founded
1. februar 2009
Share capital
DKK 62.500
Employees
8 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Company purpose
Selskabets formål er at drive speciallægeklinik og hermed ligestillet virksomhed.
Address
Østergade 9, 3.
Phone
+4586123760
Email
tid@arosklinik.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 8.318 | 10.353 | 9.010 | 10.747 | 10.872 |
| Staff expenses | -4.819 | -5.570 | -4.091 | -4.831 | -4.907 |
| EBITDA | 3.500 | 4.783 | 4.919 | 5.917 | 5.965 |
| Depreciation & amort. | -233 | -269 | -282 | -397 | -725 |
| EBIT | 3.267 | 4.514 | 4.637 | 5.520 | 5.240 |
| Net financials | 109 | 108 | 124 | 181 | 60 |
| Profit before tax | 3.376 | 4.623 | 4.761 | 5.701 | 5.300 |
| Tax | 761 | 1.037 | 1.059 | 1.266 | 1.181 |
| Net profit | 2.615 | 3.586 | 3.703 | 4.435 | 4.119 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6.203 | 7.673 | 7.407 | 8.862 | 8.823 |
| Equity | 4.256 | 5.642 | 5.844 | 6.779 | 6.899 |
| Long-term debt | 257 | 260 | 0 | 0 | 0 |
| Short-term debt | 1.690 | 1.770 | 1.563 | 2.016 | 1.868 |
| Total debt | 1.947 | 2.031 | 1.563 | 2.016 | 1.868 |
EBITDA margin
54.9%
This company
15.8%
Market median
+247% vs market
20202024
Equity ratio
78.2%
This company
38.2%
Market median
+105% vs market
20202024
Return on equity
59.7%
This company
18.4%
Market median
+224% vs market
20202024
Net profit margin
37.9%
This company
8.1%
Market median
+368% vs market
20202024
Asset turnover
1.23×
This company
1.12×
Market median
+10% vs market
20202024
Debt / equity
0.28×
This company
0.62×
Market median
+55% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
CS Founder | Founder | 2009 |
ML Management | Management | 2009 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Speciallægeholdingselskabet i Østergade ApS
SPECIALLÆGERNE I ØSTERGADE ApS Board members of SPECIALLÆGERNE I ØSTERGADE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claus Schiøtt Shah-Jørgensen | Founder | 0 companies |
| Michael Lindholt | Management | 0 companies |